These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30199560)

  • 41. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
    Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasmapheresis in treatment of acute oligoanuria in crescentic glomerulonephritis.
    Grcevska L; Polenaković M; Stojkovski L; Polenaković H
    Artif Organs; 1998 Oct; 22(10):827-30. PubMed ID: 9790079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Kokolina E; Alexopoulos E; Dimitriadis C; Vainas A; Giamalis P; Papagianni A; Ekonomidou D; Memmos D
    Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in children.
    Nash MC; Jones CL; Walker RG; Powell HR
    Pediatr Nephrol; 1993 Feb; 7(1):11-4. PubMed ID: 8439472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Case of immune complex crescentic glomerulonephritis with consistently high titers of MPO-ANCA for 6 years].
    Ayada M; Matsuo T; Takada S; Kusaura T; Suda S; Okado T; Mori Y; Tajima M; Kuwahara M; Kobayashi Y; Tsukamoto Y; Sasaki S
    Nihon Jinzo Gakkai Shi; 2007; 49(5):511-6. PubMed ID: 17695814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Rapidly progressive glomerulonephritis syndrome: course, pathomorphology and outcome (data of Kaunas University of Medicine Hospital 1996-2002)].
    Maslauskiene R; Urbanaviciene J
    Medicina (Kaunas); 2003; 39 Suppl 1():33-40. PubMed ID: 12761418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
    Shah S; Havill J; Rahman MH; Geetha D
    Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.
    Chen S; Tang Z; Xiang H; Li X; Chen H; Zhang H; Hu W; Zeng C; Liu Z
    Am J Kidney Dis; 2016 Mar; 67(3):376-83. PubMed ID: 26388283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ANCA and IgA glomerulonephritis all in one: prognosis and complications.
    Nissaisorakarn P; D'Agati V; Anis K; Jim B
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29018146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crescentic glomerular nephritis associated with rheumatoid arthritis: a case report.
    Balendran K; Senarathne LDSU; Lanerolle RD
    J Med Case Rep; 2017 Jul; 11(1):197. PubMed ID: 28732547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis.
    Chan PT; Mok CC
    Clin Rheumatol; 2012 Aug; 31(8):1273-7. PubMed ID: 22644090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case report - IgA nephropathy ANCA positive with favorable outcome.
    Barcelos FL; Fontes TM
    J Bras Nefrol; 2015; 37(3):414-7. PubMed ID: 26398653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
    Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
    Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in Taiwanese.
    Hung PH; Chiu YL; Lin WC; Chiang WC; Chen YM; Lin SL; Wu KD; Tsai TJ
    J Formos Med Assoc; 2006 Oct; 105(10):804-12. PubMed ID: 17000453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crescentic glomerulonephritis in children: a review of 43 cases.
    Srivastava RN; Moudgil A; Bagga A; Vasudev AS; Bhuyan UN; Sundraem KR
    Am J Nephrol; 1992; 12(3):155-61. PubMed ID: 1415376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ANCA-Positive pauci-immune crescentic glomerulonephritis in a patient with systemic lupus erythematosus.
    Herrera-Añazco P; Velásquez-Castillo P; Pacheco-Mendoza J; Valenzuela-Rodriguez G; Asato-Higa C
    J Bras Nefrol; 2017; 39(4):454-457. PubMed ID: 29319773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy.
    Cohen BA; Clark WF
    Am J Kidney Dis; 2000 Nov; 36(5):914-24. PubMed ID: 11054347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosis.
    Nasr SH; D'Agati VD; Said SM; Stokes MB; Appel GB; Valeri AM; Markowitz GS
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1282-8. PubMed ID: 18508945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
    Zhao L; David MZ; Hyjek E; Chang A; Meehan SM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.